Weather

66°F6:22 AM

Health

1 read

Impacto de recortes en ayuda internacional podría causar millones de muertes para 2030

KVIA•Wednesday, February 4, 2026 at 11:43 AM•CNN Newsource

Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

AI Summary

Un estudio reciente ha proyectado que los recortes en la ayuda internacional, iniciados tras la disolución de USAID, podrían resultar en 9,4 millones de muertes adicionales para el año 2030, con 2,5 millones de estas siendo niños menores de cinco años. La investigación, realizada por el Instituto de Salud Global de Barcelona, destaca que si los recortes continúan, el número de muertes podría ascender a 22,6 millones. La ayuda externa ha sido crucial en la reducción de la mortalidad infantil y en el tratamiento de enfermedades transmisibles. A pesar de las críticas a este estudio por parte de funcionarios del Departamento de Estado, expertos advierten que los recortes ya están teniendo efectos devastadores en la salud global, con sistemas de salud colapsando y datos de mortalidad difíciles de obtener.

Key Details: • Se estima que 9,4 millones de muertes adicionales podrían ocurrir para 2030 debido a recortes en ayuda. • Los recortes afectan a 93 países de ingresos bajos y medios que dependen de la ayuda exterior. • La ayuda internacional redujo la mortalidad infantil en un 39% entre 2002 y 2021. • La situación actual ya está causando muertes, aunque los datos son difíciles de recopilar.

ayuda-internacional salud-global mortalidad desarrollo recortes

People & Organizations

Marco RubioUSAIDDavide RasellaJeremy KonyndykInstituto de Salud Global de BarcelonaFundación RockefellerCenter for Global DevelopmentRefugees International

Related Articles

E. coli Outbreak Linked to Raw Cheddar Cheese Raises Health Concerns

A multistate outbreak of E. coli O157:H7 has been traced to raw cheddar cheese, with nine reported cases and three hospitalizations, including one severe case of hemolytic uremic syndrome. The outbreak, linked to a California cheese producer, has prompted renewed warnings from health officials about the dangers of consuming raw milk and its products. Children under five are particularly at risk, as over half of the affected individuals fall within this age group. Despite ongoing consumer interest in raw milk for its perceived health benefits, experts strongly advise against its consumption due to the significant health risks it poses.

New GLP-1 Weight Loss Pill Foundayo Approved with Flexible Usage Guidelines

The FDA has approved Foundayo, a new GLP-1 weight loss pill developed by Eli Lilly, offering a more flexible option for those seeking obesity treatment. Unlike the Wegovy pill, which must be taken on an empty stomach, Foundayo can be consumed at any time of day without dietary restrictions. The drug is expected to be available for home shipping starting April 6, with a monthly cost ranging from $149 to $399, depending on the dosage. Medicare coverage will begin on July 1 for eligible patients. This new medication aims to increase accessibility for the millions of Americans struggling with obesity, as current injectable options are underutilized.

Loni, India: The City Struggling with the Worst Air Quality Globally

Loni, a city near Delhi, has been identified as having the worst air quality in the world, according to IQAir's report for 2025. With an alarming average PM2.5 concentration of 112.5, which is 22 times higher than the WHO's safe limit, the city's 700,000 residents face severe health risks, including respiratory issues and cognitive impairments in children. Local residents report constant exposure to toxic air, exacerbated by industrial emissions and construction dust. Despite India's Clean Air Program initiated in 2019 aimed at reducing pollution, progress has been slow due to enforcement challenges. The ongoing pollution crisis has led some residents to consider leaving the city for better air quality elsewhere.

Cuban Cancer Patient's Journey to Uruguay Highlights Migration Crisis

Mariela, a 45-year-old Cuban woman, traveled to Uruguay for cancer treatment after receiving a positive biopsy result. Facing dire conditions in Cuba, including lack of medical supplies and constant power outages, she opted for the journey advised by her sister, a doctor. The trip, costing between $1,000 and $2,000, involved a complex route through Guyana and Brazil before reaching Uruguay, where she began chemotherapy. While her health improves, her mother remains in Cuba, struggling with advanced cancer and inadequate medical care. This situation reflects the increasing number of Cubans migrating to Uruguay, with over 22,000 arriving in 2025 alone, as they seek better healthcare and living conditions.